S.V. KHALIULLINA¹, D.E. DOLOVSKOVA², E.YU. ALATYREV², P.N. EMELYANOVA²

 ¹Kazan State Medical University, Kazan

²Republic Clinical Infectious Diseases Hospital named after Prof. A.F. Agafonov, Kazan

 Contact details:

Khaliullina S.V. — MD, Professor of the Department of Pediatric Infections

Address: 49 Butlerov St., Kazan, Russian Federation, 420012, tel.: +7 (843) 267-80-06, e-mail: svekhal@mail.ru

Damage to the nervous system is not typical for parvovirus infection, however, reports of such observations are becoming more and more widespread. We describe a case of meningitis associated with B19 parvovirus in an eight-month-old child without hematological diseases and immunodeficiency, which occurred simultaneously with staphylococcal enterocolitis. The diagnosis was made based on the detection of parvovirus B19 DNA in the cerebrospinal fluid and antibodies (Ig M) in the blood. Clinical symptoms were sparse, and the classic meningitis syndrome complex was not observed. There were also no typical manifestations of erythema infectiosum. Treatment included the administration of intravenous immunoglobulin and a short course of glucocorticosteroids. Recovery occurred 20 days after the disease onset. Observation for a month after discharge from the hospital did not show significant deviations in the child’s health.

Key words: parvovirus infection, meningitis, parvovirus B19, children.

REFERENCES

1. Barah F., Whiteside S., Batista S., Morris J. Neurological aspects of human parvovirus B19 infection: a systematic review. Rev. Med. Virol, 2014, vol. 24 (3), pp. 154-68. DOI: 10.1002/rmv.1782
2. Heegaard E.D., Brown K.E. Human parvovirus B19. Clin. Microbiol. Rev, 2002, vol. 15 (3), pp. 485–505. DOI: 10.1128/CMR.15.3.485-505.2002
3. Mortimer P.P., Humphries R.K., Moore J.G., Purcell R.H., Young N.S. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature, 1983, vol. 302 (5907), pp. 426–429. DOI: 10.1038/302426a0
4. Sim J.Y., Chang L.Y., Chen J.M., Lee P.I., Huang L.M., Lu C.Y. Human parvovirus B19 infection in patients with or without underlying diseases. J. Microbiol. Immunol. Infect, 2019, vol. 52 (4), pp. 534–541. DOI: 10.1016/j.jmii.2019.05.009
5. Adamson-Small L.A., Ignatovich I.V., Laemmerhirt M.G., Hobbs J.A. Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process. Virus Res, 2014, vol. 22 (190), pp. 8–16. DOI: 10.1016/j.virusres.2014.06.017
6. Bua G., Marrazzo P., Manaresi E., Gamberini C., Bonsi L., Alviano F., Gallinella G. Non-permissive parvovirus B19 infection: a reservoir and questionable safety concern in mesenchymal stem cells. Int. J. Mol. Sci, 2023, vol. 24 (9), p. 8204. DOI: 10.3390/ijms24098204
7. Khatami A., Razizadeh M.H., Ghadirali M., Yazdani S., Bahadory S., Soleimani A. Association of parvovirus B19 and myocarditis/dilated cardiomyopathy: A systematic review and meta-analysis. Microb. Pathog, 2022, vol. 162, p. 105207. DOI: 10.1016/j.micpath.2021.105207.
8. Waldman M., Kopp J.B. Parvovirus B19 and the kidney. Clin. J. Am. Soc. Nephrol, 2007, vol. 2 (1), pp. 47–56. DOI: 10.2215/CJN.01060307
9. Bihari C., Rastogi A., Saxena P., Rangegowda D., Chowdhury A., Gupta N., Sarin S.K. Parvovirus B19 associated hepatitis. Hepat. Res. Treat, 2013, vol. 3, pp. 472027. DOI: 10.1155/2013/472027
10. Douvoyianni M., Litman N., Goldman D.L. Neurologic Manifestations Associated with Parvovirus B19 Infection. Clin. Infect. Dis, 2009, vol. 48 (12), pp. 1713–1723. DOI: 10.1086/599042
11. Monteiro V.S., Baía-da-Silva D.C., Silva V.A., PivotoJoão G.A., Marinho E.P., Cubas-Vega N.C. et al. Neurological manifestations associated with parvovirus B19 infection in immunocompetent children: case series and systematic review. J. Tropic. Pediat, 2021, vol. 67 (4), pp. 1–9. DOI: 10.1093/tropej/fmab078
12. Hobbs J.A. Detection of adeno-associated virus 2 and parvovirus B19 in the human dorsolateral prefrontal cortex. J. Neurovirol, 2006, vol. 12, pp. 190–199.
13. Musiani M., Zerbini M., Gentilomi G., Plazzi M., Gallinella G., Venturoli S. Parvovirus B19 clearance from peripheral blood after acute infection. J. Infect. Dis, 1995, vol. 172, pp. 1360–1363.
14. Barah F., Vallely P.J., Cleator G.M., Kerr J.R. Neurological manifestations of human parvovirus B19 infection. Rev. Med. Virol, 2003, vol. 13, pp. 185–199.
15. Ferreira N.E., da Costa A.C., Kallas E.G., Silveira C.G.T., de Oliveira A.C.S., Honorato L. et al. Encephalopathy caused by human parvovirus B19 genotype 1 associated with haemophilus influenza meningitis in a newborn. Curr. Issues Mol. Biol, 2023, vol. 45, pp. 6958–6966. DOI: 10.3390/cimb45090439
16. Zou Q., Chen P., Chen J., Chen D., Xia H., Chen L. et al. Multisystem involvement induced by human parvovirus B19 infection in a non-immunosuppressed adult: a case report. Front. Med. (Lausanne), 2022, vol. 12 (9), pp. 808205. DOI: 10.3389/fmed.2022.808205
17. Guo J., Wang Y., Zhang M., Zheng H., Zang Q., Huang P. et al. Human parvovirus B19 infection in hospitalized patients suspected of infection with pathogenic microorganism. Front. Cell Infect. Microbiol, 2022, vol. 1 (12), p. 1083839. DOI: 10.3389/fcimb.2022.1083839